Agree with most comments. I was hoping for 16-17 (anything above a bonus) - hence on the surface it looks pretty ordinary. The reasons are not clear but could be last comparison 1/4 was boosted by lag payments, current 1/4 could have outstanding payments, the seasonal weather this year, a lack of demand in the cold months (could be an ongoing situation but offset by higher warmer months uptake). Just in case CUV need to widen the demand by 10-18 yo, Australia and Asia and UK. As far as recent price strength, I’m perplexed and don’t get why volumes weren’t higher and shorts reducing. I don’t imagine larger investors coming on board just did it on the basis of one quarterly but it could drop back from here also?? I’m also concerned about the whole market and more interest rate rises. Plenty of money in the bank and no debt so it still a good hold under $30 IMO. Also Mitsubishi Tanabe might still be a way off in terms of competition. GLTA
- Forums
- ASX - By Stock
- CUV
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-25
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $664.8M |
Open | High | Low | Value | Volume |
$13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 227 | $13.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.42 | 228 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3077 | 13.250 |
1 | 10 | 13.240 |
1 | 500 | 13.230 |
1 | 200 | 13.220 |
7 | 2791 | 13.200 |
Price($) | Vol. | No. |
---|---|---|
13.500 | 800 | 1 |
13.530 | 700 | 1 |
13.550 | 2500 | 1 |
13.890 | 729 | 1 |
14.000 | 2020 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online